bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.07.04.663139

Apolipoprotein E reduces the number and activation of non-invariant Natural Killer T cells

Abstract

Natural Killer T (NKT) cells, which modulate atherosclerosis, include two groups - invariant (iNKT) and variant (vNKT). These subsets differentially regulate the disease progression. Yet, the role of vNKTs in atherosclerosis remains unclear. We induced atherosclerosis by feeding high-fat diet (HFD) to Apoe-/- and analyzed the vNKTs in the liver and spleen. The vNKTs were termed non-iNKTs since they were negatively selected within the NKT population. Available literature suggests NKTs as lipid-recognizing cells; however, to our surprise, the non-iNKT numbers and phenotype remained unchanged between HFD-fed and chow-fed Apoe-/-. This was a blindsiding and unexpected outcome of the non-iNKTs being unaltered and unaffected with or without HFD, indicating no observable impact of atherosclerosis on these subsets. Albeit remaining unperturbed by atherosclerosis, these non-iNKTs demonstrated an identical but unique increase and upregulated activation in both the chow and HFD-fed Apoe-/-. These results instigated an investigation of the baseline correlation of the non-iNKTs between young C57BL/6 (WT) and Apoe-/-. Previously unknown and confounding results revealed upregulated activation and increased non-iNKT numbers but decreased IL-4+ non-iNKTs in the Apoe-/- compared to WT. Furthermore, HFD-fed WT that developed dyslipidemia, elucidated increased hepatic non-iNKTs and splenic IFN-{gamma}+ non-iNKTs compared to chow-fed WT controls. These results were not perceived in chow and HFD-fed Apoe-/-. Although lipid-responsive, non-iNKTs in Apoe-/- mice failed to respond to lipid stress, unlike those in dyslipidemic WT mice. These findings reveal that loss of Apoe, rather than atherosclerosis itself, drives altered non-iNKT biology. Thus, Apoe deficiency intrinsically dysregulates non-iNKTs, masking disease-associated immune changes. Apoe loss alters non-iNKT number and function, independent of atherosclerosis, and challenges the interpretation of immune responses by NKT subsets in Apoe-/- models. Therefore, this study warrants the use of Apoe null mice in studying NKT cells.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Chakrabarti, R., Duddu, S., Shukla, P. C.. 2025-07-07. Apolipoprotein E reduces the number and activation of non-invariant Natural Killer T cells. https://doi.org/10.1101/2025.07.04.663139

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Common viral infections seed regionally distinct resident memory T cells in the human CNS

T cells persist in the central nervous system (CNS) and can drive both protection and neurological disease. How these cells are organized in humans and what they recognize is largely unknown. Here, we profiled CD8 T cells across anatomically distinct CNS regions, obtained through on-site autopsies and temporal lobe resection surgeries, using single-cell RNA sequencing, paired T cell receptor sequencing, and DNA-barcoded tetramers. Resident memory T cells (TRM) specific for Epstein-Barr virus, cytomegalovirus, influenza A, and SARS-CoV-2 were identified across CNS compartments. Anatomical location was the strongest correlate of TRM cell state, with leptomeningeal cells adopting a cytokine-poised TRM program, whereas brain TRM cells were transcriptionally restrained. Cells of the same clonotype spanned tissues yet adopted local transcriptional states. Viral specificity added another layer of TRM heterogeneity with GZMK/GZMA-expressing EBV-specific populations and interferon-stimulated gene signatures in SARS-CoV-2 and Influenza A-specific cells. The human CNS thus harbors regionally distinct CD8+ TRM shaped by common viral exposures.

immunology↗

A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease

Rheumatic diseases, including rheumatoid arthritis (RA), spondyloarthritis (SpA) and osteoarthritis (OA), show distinct phenotypes yet respond to overlapping therapies, implicating shared immune mechanisms. In the Transimmunom cohort, we profiled peripheral blood from 240 individuals (47 healthy, 44 OA, 91 RA, 58 SpA) across deep immunophenotyping, immunoproteomics and Treg-Teff transcriptomics. Single-layer analyses revealed broader Treg than Teff remodeling, along with a shared pattern of reduced activated Tregs and expanded Helios+ Tregs across all diseases, alongside a decrease in functional Treg subpopulations, including CTLA4+ and CD45RA- Tregs. In RA specifically, LAG3+ Tregs were also expanded. Combining omics layers outperformed single-layer approaches for disease classification. Among individual layers, Treg transcriptomes were most discriminative, and integration uncovered disease-specific programs. Unsupervised clustering identified a cross-disease cluster independent of activity, treatment and age, mapping to early disease (<= years) and dominated by a Treg dysfunction-associated program. These results provide a biological rationale for the therapeutic "window of opportunity" concept and duration-stratified Treg-directed trials.

immunology↗

Inhibitory Fc Receptor sets a time limit on macrophage response to IgG

Antibodies engage both activating Fc Receptors and the inhibitory receptor Fc{gamma}RIIB. Why macrophages need a dedicated inhibitory receptor rather than simply tuning activating receptor signaling is unclear. Using DNA-based chimeric receptors and in silico modeling, we independently controlled activating and inhibitory Fc Receptors. We found that Fc{gamma}RIIB imposed a time limit on macrophage phagocytosis and ERK signaling. The time limit is due to activating Fc Receptors converting PI(4,5)P2 to PI(3,4,5)P3, which is subsequently converted to PI(3,4)P2 by Fc{gamma}RIIB. This leads to a pulse of active signaling, which is sufficient for phagocytosis of small bacteria-sized targets but not phagocytosis of large targets and TNF secretion. Unlike engaging Fc{gamma}RIIB, reducing activating Fc Receptor signaling decreased initiation of phagocytosis, the speed of PI(3,4,5)P3 generation, and the amplitude of ERK signaling. Our results demonstrate that Fc{gamma}RIIB controls the duration of IgG signaling, while the activating Fc Receptors control sensitivity.

immunology↗